SPY334.11+2.00 0.60%
DIA273.67+1.67 0.61%
IXIC11,105.50+107.10 0.97%

AstraZeneca Q2 EPS $0.96 Beats $0.44 Estimate, Sales $6.28B Beat $6.24B Estimate

AstraZeneca (NYSE:AZN) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.44 by 118.18 percent. This is a 31.51 percent increase over earnings of $0.73 per share from the same

Benzinga · -
AstraZeneca (NYSE: AZN) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.44 by 118.18 percent. This is a 31.51 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $6.28 billion which beat the analyst consensus estimate of $6.24 billion by 0.64 percent. This is a 7.85 percent increase over sales of $5.82 billion the same period last year.